Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2020

Founders Lecture: Intraocular Sustained Drug Delivery

Show Description +

Glenn Jaffe, MD, reviews the limitations of current drug delivery options for various retinal diseases and explains how engineering advances may present new therapeutic options for patients with diseases such as wet AMD and inherited retinal diseases.

Posted: 3/22/2020

Up Next

Neuroprotection for the Treatment of the Retina

Baruch Kuppermann, MD, PhD, Timothy Murray, MD, MBA


Best Approaches for Pediatric RD

Phil Ferrone, MD, Timothy Murray, MD, MBA

Perfluorocarbon Liquids: Pearls and Pitfalls

Carl Regillo, MD, Timothy Murray, MD, MBA

Subretinal Gene Therapy

Christina Weng, MD, MBA, Timothy Murray, MD, MBA

Founders Lecture: Intraocular Sustained Drug Delivery

Glenn Jaffe, MD, reviews the limitations of current drug delivery options for various retinal diseases and explains how engineering advances may present new therapeutic options for patients with diseases such as wet AMD and inherited retinal diseases.

Posted: 3/22/2020


Please log in to leave a comment.

More From ARDS: 2020 Coverage

Neuroprotection for the Treatment of the Retina

Baruch Kuppermann, MD, PhD, Timothy Murray, MD, MBA

Best Approaches for Pediatric RD

Phil Ferrone, MD, Timothy Murray, MD, MBA